Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108314646B reveals a novel Pd/Ni-MOF catalyst for Apalutamide intermediates, offering high purity, recyclability, and significant cost reduction in API manufacturing.
Patent CN104313073A reveals high-yield biocatalytic route. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.
Novel asymmetric hydrogenation route for Apremilast intermediate offering significant cost reduction and supply reliability for pharmaceutical manufacturing partners seeking high-purity intermediates globally.
Patent CN105622350B reveals a three-step resveratrol synthesis avoiding protection groups. This method reduces costs and enhances supply chain reliability for pharmaceutical intermediates.
Novel salt formation method removes dicarboxylic acid impurity ensuring high purity and yield for scalable antihypertensive drug manufacturing.
Patent CN110128411A reveals dual-target inhibitor synthesis. High yield process offers cost reduction and supply reliability for pharmaceutical manufacturing.
Novel route avoids benzyl protection, reducing steps and cost for Delgocitinib manufacturing. Ideal for reliable pharmaceutical intermediate suppliers seeking efficiency.
Patent CN104263769A details yeast-based reduction for high-purity chiral intermediates. Offers scalable, cost-effective manufacturing solutions for global supply chains.
Patent CN104263774A reveals high-yield yeast catalysis. Offers supply chain reliability and cost reduction in chiral intermediate manufacturing for global pharma.
High-purity chiral intermediate via black mold catalysis. Scalable production with significant cost and supply chain advantages for global buyers.
Patent CN104313078A reveals high-yield biocatalytic route for chiral thiazole ethanol ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN105218428A analysis reveals high purity Apremilast synthesis route. Delivers cost reduction and supply chain reliability for global pharma manufacturing partners seeking scalable API solutions.
Patent CN110790755A reveals a novel high-yield route for Canagliflozin Peroxide, offering significant cost reduction and supply reliability for SGLT2 inhibitor manufacturers.
Patent CN108409516B reveals a green microreactor method for benzophenone synthesis, offering safer production and higher yields for reliable pharmaceutical intermediate suppliers.
Patent CN117645594A details a low-cost total synthesis of Oroxylin A. This route offers significant supply chain stability and cost reduction in API manufacturing.
Advanced synthesis method for Amiodarone intermediate 2-butyl benzofuran ensuring high purity and yield. Reliable supply chain solutions for global pharmaceutical manufacturing partners.
Novel patent CN109438540A enables cost-effective steroid synthesis. Reliable supply chain for high-purity pharmaceutical intermediates with scalable production.
Patent CN101134943B reveals a novel Alcaligenes strain for >99.9% e.e. mandelic acid. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN101891767B details a high-yield method for Adefovir Dipivoxil using protective agents, offering cost reduction and supply reliability for pharmaceutical manufacturers.
Advanced synthesis of Propionyl-L-carnitine Hydrochloride via CN1995010B. Offers high purity, reduced toxicity, and scalable manufacturing for global supply chains.